(Q47856385)

6 February 2018

title

Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid (English)

1 reference

6 February 2018

0 references

1 reference

Vincent AA

1

1 reference

6 February 2018

Fanning S

series ordinal

2

1 reference

6 February 2018

Caira FC

series ordinal

3

1 reference

6 February 2018

Williamson KC

series ordinal

4

1 reference

6 February 2018

publication date

1 November 1999

1 reference

6 February 2018

published in

Parasite Immunology

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

11

1 reference

6 February 2018

page(s)

573-581

1 reference

6 February 2018

Plasmodium falciparum: D260, an intraerythrocytic parasite protein, is a member of the glutamic acid dipeptide-repeat family of proteins

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Primary structure and localization of a conserved immunogenicPlasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Limited immunological recognition of critical malaria vaccine candidate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Transmission-blocking immunity against malaria and other vector-borne diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Cross-reactive antigenic determinants present on different Plasmodium falciparum blood-stage antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Complete in vitro maturation of Plasmodium falciparum gametocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Use of Prior Vaccinations for the Development of New Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Immunodominance with progenitor B cell diversity in the neutralizing antibody repertoire to influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00255.X

10.1046/J.1365-3024.1999.00255.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

release_b6gcnfzdavcurpvesisg3l4n3u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b6gcnfzdavcurpvesisg3l4n3u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10583858

1 reference

6 February 2018